COMPLETED

Tango for Neuropathy Among Breast Cancer Survivors

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

Group dance classes have been found to improve markers of quality of life and physical health (i.e., balance) among some populations engaged in rehabilitation, such as the elderly and individuals with Parkinson Disease. However, such interventions have yet to be studied among cancer survivors despite the relevance of quality of life and physical health within cancer survivorship. Group dance classes are a promising avenue in that they deliver activity-based medicine in a social context, thus potentially improving physical as well as psychosocial aspects of health. To further this avenue of inquiry, we propose to study the effect of dance-based interventions for cancer survivors.

Official Title

Dance-Based Avenues to Advance Nonpharmacologic Treatment of Chemotherapy Effects (DAANCE)

Quick Facts

Study Start:2021-08-15
Study Completion:2024-04-15
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:COMPLETED

Study ID

NCT05114005

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:40 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Breast cancer survivor stage I-III
  2. * Symptomatic for neuropathy
  3. * postural control outside 70% CI for adults who are middle-aged without neurotrauma
  4. * having completed taxane-based chemotherapy treatment at least 3 months ago;
  5. * able to understand and comply with directions associated with testing and study treatments.
  1. * Pre-existing vestibular deficit;
  2. * poorly controlled diabetes (hgA1C \> 8);
  3. * non-ambulatory or lower extremity amputation (assistive devices allowed);
  4. * use of cytotoxic or immunotherapy during study (endocrine therapy allowed);
  5. * participation in physical therapy during the study;
  6. * contraindication to participate in Tango due to orthopedic issue (e.g., herniated vertebral disc);

Contacts and Locations

Principal Investigator

Lise Worthen-Chaudhari, PhD, MFA
PRINCIPAL_INVESTIGATOR
Ohio State University Comprehensive Cancer Center

Study Locations (Sites)

Stephanie Spielman Comprehensive Breast Center
Columbus, Ohio, 43212
United States

Collaborators and Investigators

Sponsor: Ohio State University Comprehensive Cancer Center

  • Lise Worthen-Chaudhari, PhD, MFA, PRINCIPAL_INVESTIGATOR, Ohio State University Comprehensive Cancer Center

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2021-08-15
Study Completion Date2024-04-15

Study Record Updates

Study Start Date2021-08-15
Study Completion Date2024-04-15

Terms related to this study

Additional Relevant MeSH Terms

  • Cancer, Breast
  • Neuropathy